Tweet, Tweet, Tweet: Pharma Finding Its Niche?
The industry has been slow to adopt new technologies in the highly regulated pharma world, but both big and small biopharmas alike are beginning to find their comfort zone with limited-character media like Twitter.
You may also be interested in...
A cautious patient population with long memories could thwart the potential of new hemophilia A treatments, even as the market leaders promise Wall Street that switching patients will be no problem.
Draft guidances say tweets about a product must balance benefit and risk information, and firms cannot be selective in correcting information on third-party sites.
FDA’s draft guidance on presenting product information on social media platforms with character space limitations includes an equation for sending a tweet.